NO873513D0 - Nye applikasjonsformer for aaa-interferoner. - Google Patents

Nye applikasjonsformer for aaa-interferoner.

Info

Publication number
NO873513D0
NO873513D0 NO873513A NO873513A NO873513D0 NO 873513 D0 NO873513 D0 NO 873513D0 NO 873513 A NO873513 A NO 873513A NO 873513 A NO873513 A NO 873513A NO 873513 D0 NO873513 D0 NO 873513D0
Authority
NO
Norway
Prior art keywords
interferons
aaa
new application
application forms
forms
Prior art date
Application number
NO873513A
Other languages
English (en)
Other versions
NO873513L (no
Inventor
Robert Becker
Bernd Kruss
Leonhard Schilk
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO873513D0 publication Critical patent/NO873513D0/no
Publication of NO873513L publication Critical patent/NO873513L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO873513A 1986-08-21 1987-08-20 Nye applikasjonsformer for alfa-interferoner. NO873513L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863628468 DE3628468A1 (de) 1986-08-21 1986-08-21 Neue applikationsformen fuer (alpha)-interferone

Publications (2)

Publication Number Publication Date
NO873513D0 true NO873513D0 (no) 1987-08-20
NO873513L NO873513L (no) 1988-02-22

Family

ID=6307914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873513A NO873513L (no) 1986-08-21 1987-08-20 Nye applikasjonsformer for alfa-interferoner.

Country Status (14)

Country Link
US (1) US4824674A (no)
EP (1) EP0258683A3 (no)
JP (1) JPS6351338A (no)
KR (1) KR880002541A (no)
AU (1) AU590958B2 (no)
CA (1) CA1313131C (no)
DE (1) DE3628468A1 (no)
DK (1) DK434087A (no)
FI (1) FI89007C (no)
IL (1) IL83585A0 (no)
NO (1) NO873513L (no)
NZ (1) NZ221497A (no)
PT (1) PT85561B (no)
ZA (1) ZA876166B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE3826055A1 (de) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh Mit reagenz abloesbar impraegnierte traegermatrix
JPH07501320A (ja) * 1991-10-11 1995-02-09 ギリーズ，マーク・セドリック インタ−フェロン・アルファによる眼線維症の治療
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
DE19508029C2 (de) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
AU756335B2 (en) * 1998-06-22 2003-01-09 Unihart Corporation Sticking plaster for controlled release of natural interferon
US20030206945A1 (en) * 2000-12-20 2003-11-06 Giulio Tarro Sticking plaster for controlled release of natural interferon
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
ATE457707T1 (de) 2001-12-04 2010-03-15 Active Implants Corp Kissenlagerungsimplantate für lasttragende anwendungen
WO2012064627A2 (en) 2010-11-08 2012-05-18 Genentech, Inc. Subcutaneously administered anti-il-6 receptor antibody
EP2996673A1 (en) * 2013-05-16 2016-03-23 Universiteit Antwerpen Thermolabile drug release formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055896A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Silica adsorbents in interferon purification and/or concentration
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
SE374272B (no) * 1973-08-31 1975-03-03 D A Safwat
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction
US4363634A (en) * 1980-07-18 1982-12-14 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
JPS5892621A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロンを安定に配合した製剤
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
JPS59181224A (ja) * 1983-03-29 1984-10-15 Sumitomo Chem Co Ltd 安定なインタ−フエロン製剤の製法
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3513288A1 (de) * 1985-04-13 1986-10-23 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren und vorrichtung zur beaufschlagung von augenstaebchen mit wirkstoffloesungen oder -suspensionen

Also Published As

Publication number Publication date
FI89007C (fi) 1993-08-10
FI873593A0 (fi) 1987-08-20
US4824674A (en) 1989-04-25
FI89007B (fi) 1993-04-30
IL83585A0 (en) 1988-01-31
NZ221497A (en) 1990-04-26
KR880002541A (ko) 1988-05-09
EP0258683A2 (de) 1988-03-09
CA1313131C (en) 1993-01-26
PT85561B (pt) 1990-05-31
AU590958B2 (en) 1989-11-23
DE3628468A1 (de) 1988-03-03
ZA876166B (en) 1989-05-30
NO873513L (no) 1988-02-22
JPS6351338A (ja) 1988-03-04
AU7730787A (en) 1988-02-25
EP0258683A3 (de) 1988-09-07
PT85561A (de) 1987-09-01
DK434087A (da) 1988-02-22
FI873593A (fi) 1988-02-22
DK434087D0 (da) 1987-08-20

Similar Documents

Publication Publication Date Title
DE3762617D1 (de) Tamoxifenderivate.
DE3679741D1 (de) Pseudoformatkamera.
FR2513250B1 (fr) Nouvelles cyclobutene-3,4-diones substituees
NO874159L (no) Nye lymfokin-relaterte peptider.
FI870005A0 (fi) Laogviskoesa hoegmolekulaera genom filtrering steriliserbara hyaluronsyror.
FI873581A (fi) Fast stoedanordning.
DE3689755D1 (de) Kamera.
ATE74920T1 (de) Substituierte indolochinoxaline.
NO873513D0 (no) Nye applikasjonsformer for aaa-interferoner.
FI872096A0 (fi) Foerhoejd expression av humant interleukin-2 i daeggdjursceller.
NO871870L (no) Nye retinestere.
DE3764006D1 (de) Substituierte aminoxypropanoate.
FI872154A (fi) Inaktivering av virus.
FR2593538B1 (fr) Veture perfectionnee.
DE3670823D1 (de) Changierfadenfuehrer.
DE3766279D1 (de) Substituierte aminoxypropionamide.
NO883818D0 (no) Nye forbindelser.
DK180887A (da) Drejeligt lejret kanonroer
NO872884D0 (no) Elektrodefatning.
DE3766275D1 (de) Substituierte pyrimidoindole.
DE3678326D1 (de) Lichtzuendbarer thyristor.
IT8619853A0 (it) Macchina fotografica.
NO874091D0 (no) Nye trombolytiske proteiner.
ES2012810B3 (es) Persiana-toldo perfeccionada.
NO874734L (no) Nye peptidderivater.